Early discharge after transfemoral transcatheter aortic valve implantation

Autor: Marco Barbanti, Vera Bottari, Patrizia Aruta, Davide Capodanno, Yohei Ohno, Emanuela Di Simone, Piera Capranzano, Sebastiano Immè, Simona Gulino, Giuseppe Caruso, Daniela Giannazzo, Stefano Cannata, Daniele Di Stefano, Wanda Deste, Claudia Tamburino, Martina Patanè, Corrado Tamburino, Giuseppe Gargiulo, Guilherme F. Attizzani, Carmelo Sgroi, Denise Todaro
Přispěvatelé: Barbanti, M., Capranzano, P., Ohno, Y., Attizzani, G. F., Gulino, S., Imme, S., Cannata, S., Aruta, P., Bottari, V., Patane, M., Tamburino, C., Di Stefano, D., Deste, W., Giannazzo, D., Gargiulo, G., Caruso, G., Sgroi, C., Todaro, D., Di Simone, E., Capodanno, D.
Rok vydání: 2015
Předmět:
Zdroj: Heart. 101:1485-1490
ISSN: 1468-201X
1355-6037
DOI: 10.1136/heartjnl-2014-307351
Popis: Background: The aim of this study was to assess the feasibility and the safety of early discharge (within 72 h) after transfemoral transcatheter aortic valve implantation (TAVI) and to identify baseline features and/or periprocedural variables, which may affect post-TAVI lengthofstay (LoS) duration. Methods and results: Patients discharged within 72 h of TAVI (early discharge group) were compared with consecutive patients discharged after 3 days (late discharge group). Propensity-matched cohorts of patients with a 2:1 ratio were created to better control confounding bias. Among 465 patients, 107 (23.0%) were discharged within 3 days of the procedure. Multivariable regression analysis of unmatched patients demonstrated that baseline New York Heart Association (NYHA) class IV (OR:0.22, 95% CI 0.05 to 0.96; p=0.045) and any bleeding (OR:0.31, 95% CI 0.74 to 0.92; p=0.031) were less likely to be associated with early discharge after TAVI. Conversely, the year of procedure (OR:1.66, 95% CI 1.25 to 2.20; p
Databáze: OpenAIRE